期刊文献+
共找到65篇文章
< 1 2 4 >
每页显示 20 50 100
Design,delivery and efficacy testing of therapeutic nucleic acids used to inhibit hepatitis C virus gene expression in vitro and in vivo 被引量:9
1
作者 Wolfgang H.Caselmann Matthias Serwe +3 位作者 Thomas Lehmann János Ludwig Brian S.Sproat Joachim W.Engels 《World Journal of Gastroenterology》 SCIE CAS CSCD 2000年第5期626-629,共4页
Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be ... Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be treated effectively.Toimprove this response rate we used antisensetechnologies to inhibit HCV translation as possibleadditional option for experimental treatment.Antisense oligodeoxynucleotides(ODN) are 展开更多
关键词 hepatitis C-like viruses/therapy gene expression in VITRO in vivo nucleic acids/therapeutic use CYTOMEGALOVIRUS
下载PDF
Therapeutic and Medicinal Uses of <i>Aloe vera</i>: A Review 被引量:5
2
作者 Pankaj K. Sahu Deen Dayal Giri +5 位作者 Ritu Singh Priyanka Pandey Sharmistha Gupta Atul Kumar Shrivastava Ajay Kumar Kapil Dev Pandey 《Pharmacology & Pharmacy》 2013年第8期599-610,共12页
The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, ... The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, minerals, enzymes, amino acids, natural sugars and other bioactive compounds with emollient, purgative, anti-microbial, anti inflammatory, antioxidant, aphrodisiac, anti-helmenthic, antifungal, antiseptic and cosmetic values for health care. This plant has potential to cure sunburns, burns and minor cuts, and even skin cancer. The external use in cosmetic primarily acts as skin healer and prevents injury of epithelial tissues, cures acne and gives a youthful glow to skin, also acts as extremely powerful laxative. 展开更多
关键词 ALOE vera Antimicrobial therapeutic MEDICINAL useS Cosmetic Application
下载PDF
Fentanyl and xylazine crisis:Crafting coherent strategies for opioid overdose prevention
3
作者 Lakshit Jain Jasleen Kaur +4 位作者 Shahana Ayub Danya Ansari Rizwan Ahmed Abdul Qadir Dada Saeed Ahmed 《World Journal of Psychiatry》 SCIE 2024年第6期760-766,共7页
The United States is in the throes of a severe opioid overdose epidemic,primarily fueled by the pervasive use of fentanyl and the emerging threat of xylazine,a veterinary sedative often mixed with fentanyl.The high po... The United States is in the throes of a severe opioid overdose epidemic,primarily fueled by the pervasive use of fentanyl and the emerging threat of xylazine,a veterinary sedative often mixed with fentanyl.The high potency and long duration of fentanyl is compounded by the added risks from xylazine,heightening the lethal danger faced by opioid users.Measures such as enhanced surveillance,public awareness campaigns,and the distribution of fentanylxylazine test kits,and naloxone have been undertaken to mitigate this crisis.Fentanyl-related overdose deaths persist despite these efforts,partly due to inconsistent policies across states and resistance towards adopting harm reduction strategies.A multifaceted approach is imperative in effectively combating the opioid overdose epidemic.This approach should include expansion of treatment access,broadening the availability of medications for opioid use disorder,implementation of harm reduction strategies,and enaction of legislative reforms and diminishing stigma associated with opioid use disorder. 展开更多
关键词 fentanyl XYLAZINE Opioid overdose EPIDEMIC Opioid use disorder BUPRENORPHINE Medications for opioid use disorder
下载PDF
Blastocystis hominis as a cause of chronic diarrhea in low-resource settings:A systematic review
4
作者 Stephen Amoak Jonathan Soldera 《World Journal of Meta-Analysis》 2024年第3期30-41,共12页
BACKGROUND Blastocystis hominis(B.hominis),an anaerobic unicellular protist parasite,is known for its diverse clinical manifestations upon infecting the human gastrointestinal tract.Although globally distributed,it is... BACKGROUND Blastocystis hominis(B.hominis),an anaerobic unicellular protist parasite,is known for its diverse clinical manifestations upon infecting the human gastrointestinal tract.Although globally distributed,it is particularly prevalent in developing nations.Examining the symptoms and treatment outcomes of B.hominis infection in low-resource settings holds immense significance,providing healthcare practi-tioners with valuable insights to enhance patient care.AIM To synthesize existing evidence on the symptomatology and treatment outcomes of B.hominis infection in low-resource settings.METHODS Following the Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines,a systematic review was conducted.The search spanned electronic databases including PubMed,Scopus,and Google Scholar.After a comprehensive screening process,a thorough examination of the papers,adhering to inclusion and exclusion criteria,and data extraction from eligible studies was conducted.The findings underwent summarization through simple descriptive analysis.RESULTS The search yielded 1200 papers,with 17 meeting inclusion criteria.Chronic diarrhea due to B.hominis infection was reported in only two studies,while abdominal pain,diarrhea,flatulence,constipation,and nausea/vomiting emerged as the most commonly documented symptoms.Recovery rates after one week of treatment ranged from 71.8%to 100%,and after two weeks,from 60%to 100%.CONCLUSION In low-resource settings,chronic diarrhea resulting from B.hominis infection is infrequent.Common symptoms include abdominal pain,diarrhea,flatulence,constipation,and nausea/vomiting.Post-treatment,clinical outcomes are notably favorable,supporting the recommendation for treatment.Metronidazole is advocated as the first-line agent,with consideration for switching to a second-line option in cases of treatment failure or poor response. 展开更多
关键词 Blastocystis infections Gastrointestinal diseases Treatment outcome Developing countries Metronidazole/therapeutic use
下载PDF
Continuous Wear of Hydrogel Contact Lenses for Therapeutic Use
5
作者 Daisuke Kudo Hiroshi Toshida +1 位作者 Toshihiko Ohta Akira Murakami 《Open Journal of Ophthalmology》 2012年第4期110-113,共4页
Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one w... Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one week of continuous therapeutic wear during 10 years. The reason for prescription of CLs, the primary disease, the duration of CL wear and the complications were assessed retrospectively. Results: The predominant reason for prescription of CLs was relief of pain or a foreign-body sensation (62.3%) and protection of the corneal epithelium (20.6%). The primary disease was post-penetrating keratoplasty (36.8%), followed by corneal epithelial erosion (14.5%), post-lamellar keratoplasty (14.0%) and bullous keratopathy (12.2%). The average duration of wearing single lens was 6.5 ± 3.2 days. The average duration of wearing CLs in total was 9.2 ± 10.7 months. The most frequent problem associated with continuous wear of CLs was their dropping out of CLs (12.3%). The complications associated with CLs included conjunctivitis with papillary hyperplasia, corneal erosion and superficial punctate keratitis, but corneal ulcer and corneal infiltrates were not found. Conclusion: Serious complications were not shown changing the lenses every week to keep to the prescribed time limit for continuous therapeutic wear, even if corneal epithelial barrier function is impaired. 展开更多
关键词 therapeutic use BANDAGE Soft Contact LENS CONTINUOUS WEAR COMPLICATION
下载PDF
Comparison of long-lasting therapeutic effects between succimer and penicillamine on hepatolenticular degeneration 被引量:3
6
作者 REN Ming Shan, ZHANG Zhi, WU Jun Xia, LI Fei, XUE Ben Chun and YANG Ren Min 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第6期75-77,共3页
AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. ... AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. Group A ( n =60) received Suc 750mg , po. bid. Group B ( n =60) received Pen 250mg , po. qid. The period of maintenance treatment varied from 6 months to 3 years, averaging 1 5 years. Symptoms and therapeutic effects were evaluated by modified Goldstein scale. RESULTS The total effectiveness of group A in two different periods of treatment were 80% and 85% respectively, higher than those of group B (58% and 59% respectively) ( P <0 05). Suc also had obvious curative effects for the patients who failed in the use of Pen. There were fewer side effect in group A than in group B ( P <0 05). Suc and Pen could increase urinary copper excretion effectively and continually. CONCLUSION Suc is more effective and safer than Pen. Clinically, it can replace Pen as first choice drug for long term maintenance therapy of HLD. 展开更多
关键词 hepatolenticular degeneration/drug THERAPY succimer/therapeutic use penicillamine/therapeutic use
下载PDF
Functional dyspepsia of ulcer-dysmotility type:clinical incidence and therapeutic strategy 被引量:3
7
作者 WANG XiaoZhong and LIN GuZhen 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第4期95-96,共2页
Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhe... Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhenSubjectheaadings... 展开更多
关键词 dyspepsia/drug therapy famotidine/therapeutic use cisapride/therapeutic use peptic ULCER gastrointestinal motility
下载PDF
Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract 被引量:5
8
作者 Tsunenori Kondo Toshio Takagi Kazunari Tanabe 《World Journal of Clinical Oncology》 CAS 2015年第6期237-251,共15页
Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional n... Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional nodes for tumors of the right renal pelvis or the right upper two-thirds of the ureter. A prospective study showed that an anatomical templatebased lymphadenectomy significantly improved patient survival in tumors of the renal pelvis. This benefit was more evident for patients with p T2 stage tumors or higher. The risk of regional node recurrence is significant reduced by template-based lymphadenectomy,which is likely to be associated with improved patient survival. The removal of lymph node micrometastases is assumed to be the reason for therapeutic benefit following lymphadenectomy. The number of resected lymph nodes can be used to assess the quality of lymphadenectomy,but not to determine the extent of lymphadenectomy. The guidelines currently recommend lymphadenectomy for patients with muscle-invasive disease,even though the current recommendation grades are still low. The present limitation of lymphadenectomy is the lack of standardization of the extent of lymphadenectomy and the randomized trials. Further studies are warranted to collect the evidence to support lymphadenectomy. 展开更多
关键词 LYMPHADENECTOMY LYMPH node EXCISION UROTHELIAL carcinoma Treatment outcome therapeutic uses Diagnosis GUIDELINE
下载PDF
Intracranial Abscess Post Intravenous Misuse of Transdermal Fentanyl in an Immunocompetent Patient
9
作者 Hazel Serrao-Brown 《Open Journal of Modern Neurosurgery》 2018年第2期143-146,共4页
Infections, including intracranial abscesses, are a well-known and potentially serious complication of intravenous drug abuse. There have been increasing reports of intravenous misuse of transdermal Fentanyl, with sev... Infections, including intracranial abscesses, are a well-known and potentially serious complication of intravenous drug abuse. There have been increasing reports of intravenous misuse of transdermal Fentanyl, with severe sequelae. Intracranial abscesses in intravenous drug users tend to involve uncommon pathogens, and may present with atypical symptoms, which can lead to delayed diagnosis and inadequate treatment. We present the case of a 28-year-old female, with a history of intravenous misuse of transdermal Fentanyl, who was found to have intracranial abscesses with Fusobacterium nucleatum and Nocardia species, causing significant vasogenic oedema and mass effect. 展开更多
关键词 INTRACRANIAL ABSCESS TRANSDERMAL fentanyl INTRAVENOUS DRUG use
下载PDF
Controversies regarding transplantation of mesenchymal stem cells
10
作者 Tsvetelina Velikova Tereza Dekova Dimitrina Georgieva Miteva 《World Journal of Transplantation》 2024年第2期48-61,共14页
Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intric... Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intricate landscape of MSC controversies,drawing upon 15 years of clinical experience and research.We delve into the fundamental properties of MSCs,exploring their unique immuno-modulatory capabilities and surface markers.The heart of our inquiry lies in the controversial applications of MSC transplantation,including the perennial debate between autologous and allogeneic sources,concerns about efficacy,and lingering safety apprehensions.Moreover,we unravel the enigmatic mechanisms surro-unding MSC transplantation,such as homing,integration,and the delicate balance between differentiation and paracrine effects.We also assess the current status of clinical trials and the ever-evolving regulatory landscape.As we peer into the future,we examine emerging trends,envisioning personalized medicine and innovative delivery methods.Our review provides a balanced and informed perspective on the controversies,offering readers a clear understanding of the complexities,challenges,and potential solutions in MSC transplantation. 展开更多
关键词 Mesenchymal stem cells Transplantation controversies Regenerative medicine Autoimmune diseases Chronic inflammatory illnesses Tumor growth METASTASIS therapeutic potential Clinical use of mesenchymal stem cell
下载PDF
Clinacanthus nutans:a review of the medicinal uses,pharmacology and phytochemistry 被引量:10
11
作者 Md.Ariful Alam Sahena Ferdosh +4 位作者 Kashif Ghafoor Md.Abdul Hakim Abdul Shukor Juraimi Alfi Khatib Md.Zaidul I.Sarker 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2016年第4期393-399,共7页
Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bite... Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bites,lesions caused by herpes simplex virus,diabetes,and gout in Malaysia.Indonesia.Thailand and China.Phylochemieal investigations documented the varied contents of bioaclive compounds from litis plant namely flavonoids,glycosides,glycoglyeerolipids.cerebrosides and monoacylmonogalatosylglycerol.The pharmacological experiment proved that various types of extracts and pure compounds from this species exhibited a broad range of biological properties such as anti-inflammatory,antiviral,antioxidant,and anti-diabetic activities.The lindings of toxicity study showed that extracts from this plant did not show any toxicity thus it can be used as strong therapeutic agents for specific diseased conditions.However,further experiments on chemical components and their mode of action showing biological activities are required to elucidate the complete phytochemical profile and assess to confirm their suitability tor future drugs.This review summarizes the medicinal uses,phytochemistry and pharmacology of this plant in order to explore its therapeutic potential and gaps necessitating for prospected research work. 展开更多
关键词 Clinacanthus nutans MEDICINAL useS PHYTOCHEMICALS PHARMACOLOGY therapeutic potential
下载PDF
High-intensity focused ultrasound extracorporeal ablation of liver tissuesin rabbits
12
《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第2期16-16,共1页
HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZ... HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZhaoYou1,YUYao1,B... 展开更多
关键词 LIVER neoplasms experimental/therapy ultrasonic THERAPY iodized oil/therapeutic use liver/radiation effects randomized controlled trials
下载PDF
The role of drug utilization evaluation in medical sciences
13
作者 Ruby Gangwar Arvind Kumar +2 位作者 Abrar Ahmed Zargar Amit Sharma Ranjeet Kumar 《Global Health Journal》 2023年第1期3-8,共6页
Background:Drug utilization evaluation(DUE)is defined by the World Health Organization(WHO)and focuses on the medical,social,and economic consequences of pharmaceutical marketing,distribution,prescribing,and usage in ... Background:Drug utilization evaluation(DUE)is defined by the World Health Organization(WHO)and focuses on the medical,social,and economic consequences of pharmaceutical marketing,distribution,prescribing,and usage in society.The WHO recommends a physician to every 1000 people.According to the recent data from the Health Ministry in 2019,in which 1.16 million doctors are of active population with just 80%,or 0.9 million,practicing.As a result,a ratio of 0.68 doctors for every 1000 people,which is much below as per the WHO reports.This article describes history,types,WHO guidelines,need and purpose of DUE.Objective:The main aim of this paper is to provide information about the rational use of medication in outpa­tient and inpatient department with special emphasis of DUEs.It also provides awareness directly to healthcare professionals,researchers,academicians,pharmacist and nurses to reduce the irrationality of medicines.Methods:The method used to compile this review information gathered from websites,Google scholar,PubMed,Research gate,and studies published on DUE from July 20 to Oct 22 were included as source of information.Results:We studied more than 35 published study on DUE,that reveals most of the physicians prescribed branded drugs not generic drugs,but WHO prescribing indicator allows to prescribe generic drugs in the hospital pharmacy to maintain better inventory control.It may also help to prevent pharmacist misunderstanding during dispensing.Conclusion:The use of generic prescription names avoids the possibility of medication product duplication and lowers patient costs.It is important to remember that incorrect medication prescriptions have impact on both patients and their family members.WHO indicators identify irrational prescribing behaviours to make therapy more rational and cost-effective. 展开更多
关键词 Anatomical therapeutic chemical classification Drug utilization evaluation Prescribing indicators Pregnancy risk classification Rational use of the drug
下载PDF
USE OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL THERAPEUTICS
14
作者 Doo Suk Lee Min-Jung Bae Sunyoung Kim 《World Journal of Traditional Chinese Medicine》 2015年第4期91-91,共1页
The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of b... The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of biologically active molecules generates major difficulties associated with botanical therapeutics in general.This includes management of raw materials,poor understanding of 展开更多
关键词 use OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL therapeuticS PG
原文传递
大剂量芬太尼透皮贴剂治疗晚期癌痛的临床观察 被引量:19
15
作者 戴永美 崔同建 +2 位作者 林贵山 郑建萍 曾婧 《现代肿瘤医学》 CAS 2016年第3期466-467,共2页
目的:观察大剂量芬太尼透皮贴剂治疗晚期癌痛的近期疗效及不良反应,评价其安全性。方法:使用大剂量芬太尼透皮贴剂(剂量≥300μg/h)治疗晚期癌痛5例,观察其止痛疗效及不良反应。结果:5例患者疼痛得到较好控制。出现便秘3例,1例患者出现... 目的:观察大剂量芬太尼透皮贴剂治疗晚期癌痛的近期疗效及不良反应,评价其安全性。方法:使用大剂量芬太尼透皮贴剂(剂量≥300μg/h)治疗晚期癌痛5例,观察其止痛疗效及不良反应。结果:5例患者疼痛得到较好控制。出现便秘3例,1例患者出现头晕,1例患者出现嗜睡,经对症处理后均可缓解。未出现呼吸抑制、肝肾功能损害等不良反应。未出现治疗相关性死亡。结论:大剂量芬太尼透皮贴剂治疗晚期癌痛疗效满意,合理用药是安全有效的,其毒副反应可以耐受。 展开更多
关键词 芬太尼透皮贴剂 疗效 不良反应 安全性
下载PDF
柴胡疏肝散辅助芬太尼透皮贴治疗肝癌疼痛 被引量:12
16
作者 吴敏华 周月芬 +3 位作者 陈旭烽 朱月娇 谢艳茹 涂建飞 《中西医结合肝病杂志》 CAS 2013年第2期83-85,共3页
目的:随机双盲法观察柴胡疏肝散辅助芬太尼透皮贴治疗肝癌疼痛的效果。方法:50例晚期肝癌伴疼痛患者随机分为观察组和对照组,每组25例。观察组患者开始每72小时外用芬太尼透皮贴4.2mg(25μg/h)1张,每日给予中药疏肝理气的代表方剂柴胡... 目的:随机双盲法观察柴胡疏肝散辅助芬太尼透皮贴治疗肝癌疼痛的效果。方法:50例晚期肝癌伴疼痛患者随机分为观察组和对照组,每组25例。观察组患者开始每72小时外用芬太尼透皮贴4.2mg(25μg/h)1张,每日给予中药疏肝理气的代表方剂柴胡疏肝散口服;对照组患者开始每72小时外用芬太尼透皮贴4.2mg(25μg/h)1张,每日给予中药安慰剂口服。以吗啡注射液皮下注射治疗爆发痛。用数字疼痛评估法(NRS)记录疼痛评分,根据前24小时阿片类药物总量计算并增加芬太尼透皮贴剂量;连续用药并观察21天,评价两组患者疼痛评分、疼痛缓解率、芬太尼透皮贴使用剂量、不良反应。结果:治疗后两组疼痛评分均较治疗前明显下降(P<0.01),治疗后两组间癌痛缓解率、疼痛评分及不良反应均无统计学差异(P>0.05);芬太尼透皮贴平均使用剂量分别为观察组(68.18±25.80)μg/h、对照组(89.13±37.56)μg/h,两组有统计学差异(P<0.05)。结论:芬太尼透皮贴能有效治疗肝癌疼痛;柴胡疏肝散能减少芬太尼透皮贴治疗晚期肝癌疼痛的剂量。 展开更多
关键词 肝肿瘤 疼痛 镇痛 柴胡疏肝散/治疗应用 芬太尼透皮贴/治疗应用
下载PDF
小剂量罗哌卡因复合芬太尼腰麻在宫腔镜手术中的应用 被引量:4
17
作者 黄晓雷 齐晓非 +3 位作者 曹君 吴铭广 谷寅 李元涛 《陕西医学杂志》 CAS 2010年第5期552-554,共3页
目的:探讨小剂量罗哌卡因复合芬太尼腰麻用于宫腔镜手术的可行性。方法:180例拟在腰麻下行宫腔镜手术患者随机分为三组,每组60例。R10组给予罗哌卡因10mg,R5组给予罗哌卡因5mg,RF组给予罗哌卡因5mg+芬太尼15μg,三组均选L2~3间隙穿刺,... 目的:探讨小剂量罗哌卡因复合芬太尼腰麻用于宫腔镜手术的可行性。方法:180例拟在腰麻下行宫腔镜手术患者随机分为三组,每组60例。R10组给予罗哌卡因10mg,R5组给予罗哌卡因5mg,RF组给予罗哌卡因5mg+芬太尼15μg,三组均选L2~3间隙穿刺,用脑脊液稀释至2ml,针尖朝头,注药时间8s。监测记录患者循环功能、感觉阻滞程度、运动阻滞程度及不良反应。结果:RF组与R10组相比,感觉阻滞平面、麻醉效果优良率无显著性差异,用药后R10组血压下降、心率减慢(P<0.01),但RF组变化不明显,RF组用药后60minBromage评分高于R10组(P<0.01),运动阻滞程度明显轻于R10组;RF组与R5组相比,两组用药后血压、心率变化均不明显,用药后60minBromage评分无显著性差异,但RF组感觉阻滞平面、麻醉效果优良率高于R5组(P<0.01)。结论:小剂量罗哌卡因(5mg)复合芬太尼(15μg)腰麻用于宫腔镜手术感觉阻滞完善、麻醉效果满意,对血流动力学影响小,运动阻滞轻,不良反应少。 展开更多
关键词 麻醉 脊椎 酰胺类/治疗应用 芬太尼/治疗应用 宫腔镜检查
下载PDF
腰丛-坐骨神经联合阻滞在老年人下肢手术中的应用及对围手术期应激反应的影响 被引量:3
18
作者 张昕 王晖 +1 位作者 王臻 兰自侃 《陕西医学杂志》 CAS 北大核心 2007年第7期826-828,共3页
目的:探讨腰丛-坐骨神经联合阻滞和硬膜外麻醉在老年人下肢手术中的应用,比较两者临床麻醉起效和恢复时间、术后镇痛效果、血液动力学的变化及围术期应激反应的影响。方法:48例拟行单侧下肢手术的老年病人,随机分为腰丛-坐骨神经联合阻... 目的:探讨腰丛-坐骨神经联合阻滞和硬膜外麻醉在老年人下肢手术中的应用,比较两者临床麻醉起效和恢复时间、术后镇痛效果、血液动力学的变化及围术期应激反应的影响。方法:48例拟行单侧下肢手术的老年病人,随机分为腰丛-坐骨神经联合阻滞(NER)和硬膜外麻醉(EPI)。记录麻醉前,手术开始后15、30、45、60min,术后1h的收缩压(SBP)、舒张压(DBP)和心率(HR),以及感觉、运动神经阻滞起效及恢复时间、镇痛维持时间、效果及术前、术中、术毕的血浆皮质醇、血糖及胰岛素水平。结果:手术开始后15min,EPI组病人DBP降低明显,随后30、45、60min及术后1hEPI组病人的SBP、DBP均明显低于NER组;NER组感觉、运动神经阻滞起效时间均小于EPI组,恢复时间明显长于EPI组;两组血浆皮质醇、血糖、胰岛素均较术前明显升高,EPI组升高幅度小于NER组。结论:神经刺激器定位下行腰丛-坐骨神经联合阻滞,麻醉效果佳,且有效抑制应激反应。 展开更多
关键词 麻醉 麻醉药 联用 芬太尼/治疗应用 利多卡因/治疗应用 应激 围手术期医护 老年人
下载PDF
应用芬太尼透皮贴剂治疗中重度癌痛的临床体会 被引量:3
19
作者 李钧 赵慰冲 +1 位作者 于会明 张楠 《中国肿瘤临床》 CAS CSCD 北大核心 2006年第9期524-526,共3页
目的:观察芬太尼透皮贴剂(多瑞吉)治疗中重度癌性疼痛的疗效及不良反应。方法:回顾性分析采用多瑞吉治疗的慢性中重度疼痛患者中,经济上能完全按照滴定要求用药,且未化疗、放疗、使用破骨细胞抑制剂治疗的66例患者的临床疗效。未曾应用... 目的:观察芬太尼透皮贴剂(多瑞吉)治疗中重度癌性疼痛的疗效及不良反应。方法:回顾性分析采用多瑞吉治疗的慢性中重度疼痛患者中,经济上能完全按照滴定要求用药,且未化疗、放疗、使用破骨细胞抑制剂治疗的66例患者的临床疗效。未曾应用阿片类药物的患者均从25!g/h开始,3天一换,每次加量25!g/h直至满意疗效。使用过阿片类药物的患者按等效止痛换算法来计算多瑞吉剂量。结果:完全缓解30例(45.4%),明显缓解25例(37.8%),中度缓解5例(7.57%),轻度缓解2例(3.03%),总缓解率90.9%;副反应主要有:嗜睡10例(15.1%),恶心15例(22.7%),呕吐6例(9.09%),口干2例(3.03%),便秘13例(19.7%),排尿困难6例(9.09%),中断治疗3例(恶心、呕吐2例,嗜睡1例),完全无副反应15例(22.7%)。结论:多瑞吉使用方便安全,是目前在临床上用以控制中重度癌痛的有效药物。 展开更多
关键词 芬太尼透皮贴剂(多瑞吉) 癌痛 治疗效果 不良反应
下载PDF
芬太尼透皮贴剂治疗癌痛 被引量:4
20
作者 王红兵 张敬川 +2 位作者 朱正秋 高超 刘德生 《徐州医学院学报》 CAS 2006年第4期353-355,共3页
目的评价芬太尼透皮贴剂治疗癌痛的止痛疗效及安全性。方法观察92例癌痛患者接受芬太尼透皮贴剂止痛治疗的临床疗效及不良反应,数字评分法评估疼痛程度。结果治疗前疼痛程度评分均值为7.4;治疗后第13、、69、、15、30天疼痛程度评分分... 目的评价芬太尼透皮贴剂治疗癌痛的止痛疗效及安全性。方法观察92例癌痛患者接受芬太尼透皮贴剂止痛治疗的临床疗效及不良反应,数字评分法评估疼痛程度。结果治疗前疼痛程度评分均值为7.4;治疗后第13、、69、、15、30天疼痛程度评分分别降低至4.1、3.1、2.5、2.2、1.9和1.6,总有效率为96.7%。使用芬太尼透皮贴剂的初始、第15天和第30天用药剂量均值分别为32.4μg/h、42.6μg/h和49.6μg/h。不良反应主要有便秘、恶心、头晕、呕吐、嗜睡和呼吸抑制。结论芬太尼透皮贴剂治疗癌痛安全有效,可作为中重度癌痛治疗的首选药物之一。 展开更多
关键词 芬太尼透皮贴剂 癌痛 疗效
下载PDF
上一页 1 2 4 下一页 到第
使用帮助 返回顶部